BullFrog AI posts investor presentation outlining causal AI platform for drug discovery, R&D optimization
BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026
BullFrog AI Increases CEO Pay Amid Governance Continuity
BullFrog AI Sets 2026 Annual Meeting, Proposal Deadline
Bullfrog AI Holdings shares are trading higher after the company announced that it secured funding into late 2027.
BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners